Cationic
bolaamphiphile polymers had been previously studied as efficient delivery system for the delivery of
proteins with relatively low toxicity. Here, the authors investigate the use of a
protein delivery system based on a cationic
bolaamphiphile to sensitize
cancer cells toward apoptosis-inducing drugs as a novel approach for
cancer therapy. The authors demonstrates the efficacy of the system by two strategies. The first strategy involves delivery of a
survivin antibody to inhibit
survivin activity. Sensitization of MCF-7 cells to
doxorubicin is observed by
survivin inhibition by
antibodies. The IC50 of
doxorubicin is reduced ≈2.5-fold after delivery of
survivin antibodies to
breast cancer cells and induction of apoptosis is shown by Western blotting with apoptosis specific
antibodies. In a second approach, functional wild type p53 is delivered into p53-null
liver cancer (Hep3B) cells, sensitizing the cells toward the p53 pathway
drug, Nutlin. Nutlin reduced the viability of Hep3B cells by ≈42% at 15 μM concentration, demonstrating the effectiveness of p53 delivery. The expression of p21, a downstream target of p53 further confirmed the functional status of the delivered
protein. In conclusion. The successful delivery of
apoptosis inducing proteins and sensitization of
cancer cells via cationic
bolaamphiphile polymer represents a promising system for
cancer therapeutics.